Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and inhibits hepatocellular carcinoma

BACKGROUND & AIMS: Epidemiological studies have shown that obesity is a risk factor for hepatocellular carcinoma (HCC). Lower adiponectin levels are associated with poor prognosis in obese HCC patients hence it is plausible that adiponectin acts as a negative regulator of HCC. Here, we investiga...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Saxena, Neeraj K., Fu, Ping P., Nagalingam, Arumugam, Wang, Jason, Handy, Jeffrey, Cohen, Cynthia, Tighiouart, Mourad, Sharma, Dipali, Anania, Frank A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2967590/
https://ncbi.nlm.nih.gov/pubmed/20637208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2010.07.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller